American depositary receipts of French biotechnology firm Abivax rose more than sixfold premarket after a drug candidate for bowel condition ulcerative colitis showed promise in a late-stage clinical ...

Tesla's stock has rallied on the day after that past three earnings reports, which is the longest streak in at least five years, according to available FactSet data back to April 2020. The gains were ...

Asian investors need to figure out where to put their trillions, and don’t want to over invest in the U.S., says Morgan ...

The U.S.-listed stocks of Japanese companies are surging, amid investor enthusiasm over the U.S-Japan trade deal. The biggest gainers were the ADRs of automakers, as Toyota's stock was ...

That said, banks and credit unions offering the best available yields for 3-year maturity terms are promising more than three ...

NextEra Energy recorded a bigger profit on climbing revenue in the second quarter, though it provided earnings guidance through 2027 that may underwhelm analysts. The nuclear-energy company posted a ...

Have an issue with your financial planner or looking for a new one? Email questions or concerns to [email protected].

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Fiserv struck a deal with Canadian lender TD Bank Group to provide technology, including its Clover point-of-sale system, to some of the bank's business clients while acquiring about 3,400 merchant ...

Data from Goldman Sachs' prime brokerage shows that quantitative strategies are suffering their worst drawdown since the end of 2023. So-called systematic managers (that trade through Goldman) have ...

In ANI's New Day trial, patients were randomized to an induction phase to receive either a single Iluvien injection or a series of five monthly injections of aflibercept, followed by supplemental ...

Alphabet's second-quarter results after the bell should show continued growth in profit and revenue. Specifically, analysts tracked by FactSet expect the company to post $2.18 in earnings per share, ...